ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Syndrome
Human Influenza

COVID-19 trials near Los Angeles, CA, USA:

Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

Los Angeles, California, United States and 108 other locations

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Los Angeles, California, United States and 123 other locations

This is a Phase II multi-center, double-blind, placebo-controlled, randomized study in Patients with moderate to severe lung injury due to COVID...

Enrolling
Covid19
Biological: hMSC

Phase 2

Stemedica Cell Technologies

Santa Monica, California, United States and 1 other location

COVID-19 patients who develop severe disease often develop acute respiratory distress syndrome (ARDS) as a result of a dysregulated...

Enrolling
COVID-19
ARDS
Other: SOC plus Placebo IV
Biological: SOC plus 15mg/kg EB05 IV

Phase 2, Phase 3

Edesa Biotech

Fullerton, California, United States and 19 other locations

stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...

Enrolling
COVID-19
Device: RD-X19
Device: Sham
EmitBio

West Hollywood, California, United States and 47 other locations

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
COVID-19
SARS-CoV-2
Drug: Normal saline
Drug: VYD222

Phase 3

Invivyd

Culver City, California, United States and 17 other locations

The primary objective of this study is to evaluate the safety and tolerability of intravenous (IV) IMM-BCP-01 in subjects with mild to moderate COVID...

Enrolling
COVID-19
SARS-CoV2 Infection
Drug: Placebo
Drug: IMM-BCP-01

Phase 1

Immunome, Inc.

Long Beach, California, United States of America and 2 other locations

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting
COVID-19 Disease
Drug: Placebo oral capsule
Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Newport Beach, California, United States of America and 28 other locations

The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a singl-...

Active, not recruiting
COVID-19
Influenza, Human
Other: Normal saline placebo
Biological: BNT162b2 (Omi XBB.1.5)

Phase 2

Pfizer
Pfizer

Tustin, California, United States and 29 other locations

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

Los Angeles, California, United States and 217 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems